<DOC>
	<DOCNO>NCT00375609</DOCNO>
	<brief_summary>Randomized study PRT054021 40 mg 15 mg bid vs. enoxaparin 30 mg q12h prophylaxis venous thromboembolic event unilateral knee replacement surgery .</brief_summary>
	<brief_title>Factor Xa Inhibitor , PRT054021 , Against Enoxaparin Prevention Venous Thromboembolic Events ( EXPERT )</brief_title>
	<detailed_description>Approximately 200 patient undergoing unilateral knee replacement enter study randomize receive either enoxaparin 30 mg sq bid , PRT054021 15 mg po bid , PRT054021 40 mg po bid 10 14 day , time patient undergo venography .</detailed_description>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Factor Xa Inhibitors</mesh_term>
	<criteria>• The subject undergone elective primary unilateral TKR ( unicompartmental ) . Demographic The subject age 18 75 year . If subject woman , without reproductive potential ( postmenopausal ≥2 year hysterectomy ) . The subject weigh 50 kg ( 110 lb ) 120 kg ( 265 lb ) . Laboratory Procedures The subject willing able undergo unilateral venography . Medications The subject willing able selfinject enoxaparin receive injection q12h caregiver . Ethical • The subject able read give write informed consent sign informed consent form approve Investigator 's IRB/IEC . Disease Related Major medical and/or surgical condition may impair oral drug absorption metabolism . Immobilization 3 day surgery . History ( include family history ) symptoms congenital acquire bleed disorder vascular malformation ; history intracranial , retroperitoneal , intraocular bleeding within last 6 month ; felt high risk bleed reason . Gastrointestinal bleeding within 90 day surgery endoscopically verified ulcer disease within 30 day surgery . Indwelling intrathecal epidural catheter prophylaxis period ( except epidural catheter remove surgery ) ; unusual difficulty administer spinal epidural anesthesia ( eg , 3 attempt , `` traumatic tap '' ) . Major surgery , ischemic stroke , myocardial infarction within 3 month Screening . Uncontrolled hypertension define systolic blood pressure ( SBP ) &gt; 180 mmHg diastolic blood pressure ( DBP ) &gt; 105 mmHg . Hypotension define SBP &lt; 95 mmHg . Evidence Screening symptomatic congestive heart failure require treatment . Chronic atrial fibrillation treat oral anticoagulant , recurrent atrial arrhythmia ( ) history recurrent ventricular tachycardia . Laboratory Procedures Evidence Screening : platelet count &lt; 100,000/mm3 potassium &lt; 3.5 mEq/L hemoglobin concentration &lt; 10 g/dL hematocrit &lt; 30 % serum ALT AST &gt; 2 time ULN serum creatinine &gt; 2.0 mg/dL ( 180 µm/L ) Contraindication venography , include iodinate contrast medium QTc Screening ECG &gt; 450 msec and/or personal family history `` Long QT Syndrome '' . Medications Contraindication anticoagulation VTE prophylaxis , include contraindication receive heparin heparinoids . Administration follow drug within 7 day TKR : thrombolytic agent , anticoagulant and/or antiplatelet agent ( eg , heparin , warfarin , dipyridamole , sulfinpyrazone , ticlopidine , dextran , clopidogrel ) . Aspirin 325 mg daily NSAIDs allow discourage . Use class III antiarrhythmic drug ( eg , dofetilide , ibutilide , amiodarone , bretylium , sotalol ) within 30 day prior TKR . General Participation investigational drug study 30 day prior enrollment prohibit . Participation device trial prior enrollment acceptable . Any condition could interfere treatment might interfere conduct study , would , opinion Investigator , unacceptably increase risk subject 's participation study . This would include , limited alcoholism , drug dependency abuse , psychiatric disease , epilepsy unexplained blackout .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Prevention Venous Thromboembolism</keyword>
</DOC>